Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (1)
  • 2022 (5)
  • 2021 (11)

Subject

  • Synthetic drugs (66)
  • Drug Trafficking (63)
  • Seizures (Drugs/Property) (44)
  • Task Forces/Task Force Officers (42)
  • Fake Pills (36)
  • Overdose (25)
  • Prescription Drugs (21)
  • Major Law Enforcement Operation (20)
  • OCDETF/Task Force (20)
  • Arrests/Convictions - Major (19)
  • Guns/Weapons (19)
  • Outreach/Drug Prevention (16)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • Gangs (8)
  • Guilty Plea (8)
  • One Pill Can Kill (8)
  • Dark Web- Internet Trafficking (5)
  • Fentanyl Awareness (5)
  • Press Conferences (5)
  • Congressional Affairs (3)
  • Money Laundering (3)
  • Narcoterrorism (3)
  • HIDTA (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Take Back Day (1)
  • Diversion Division (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)

Drug Name

  • Opioids (49)
  • Fentanyl (46)
  • Oxycodone (40)
  • Methamphetamine (15)
  • Hydromorphone (13)
  • Benzodiazepines (8)
  • Morphine (6)
  • Amphetamines (4)
  • Methadone (4)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Synthetic Opioids (18)

Field Division

  • Washington, DC (14)
  • Chicago (1)
  • New Jersey (1)
  • New York (1)
  • Sede (1)
Clear All Results
PRESS RELEASE

DEA Washington Division Calls on the Community to Have Important Conversations on Dangers of Drugs and Fake Pills in Back-To-School Routines

Agosto 22, 2024
Washington, DC – As schools in the District of Columbia, Maryland, and Virginia open their doors to students and teachers this month, the Drug Enforcement Administration (DEA) Washington Division is urging the community to have important conversations about the consequences of drug experimentation and misuse as the new school year...
Agosto 22, 2024
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Enero 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
Enero 24, 2023
PRESS RELEASE

Amherst County Veterinarian Sentenced for Opioid Theft

Junio 22, 2022
LYNCHBURG, Va. – A former veterinarian, who admitted to stealing opioids, was sentenced today to eight months in federal prison. Patrick Gries, 54, of Madison Heights, Virginia, pleaded guilty in January 2022 to one count of adulteration of a drug held for sale after shipment in interstate commerce and one...
Junio 22, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

La DEA Inicia el Primer Año de la Operación Engage en Richmond, VA

Mayo 06, 2022
Richmond, Virginia – Hoy, la División de Washington de la Administración para el Control de Drogas (DEA, por sus siglas en inglés) anunció el inicio de la Operación Engage en Richmond, Virginia. La cual es una iniciativa integral a nivel comunitario implementada para combatir y abordar los problemas asociados a...
Mayo 06, 2022
PRESS RELEASE

DEA Launches First Year of Operation Engage in Richmond, VA

Mayo 06, 2022
Richmond, Va., – Today, the Drug Enforcement Administration's (DEA) Washington Division announces the launch of Operation Engage in Richmond, Virginia. Operation Engage is comprehensive, community-level initiative, implemented to target and address the drug and related violence issues in cities with high levels of drug related problems. Operation Engage is new...
Mayo 06, 2022
PRESS RELEASE

DEA & MPD Issue Public Safety Alert on Mass Overdose Events Across D.C. Metro Area

Abril 14, 2022
Washington, D.C., -- Today, the Drug Enforcement Administration (DEA) Washington Division & the Metropolitan Police Department issued a Public Safety Alert warning residents in the D.C. metropolitan area of the alarming increase in fentanyl-related mass overdose events across the city. The Public Safety Alert seeks to raise public awareness of...
Abril 14, 2022
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

Noviembre 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
Noviembre 19, 2021
PRESS RELEASE

Ringleader and Members of Multi-State Anabolic Steroid Trafficking Network Sentenced

Noviembre 02, 2021
NORFOLK, Va. – Today, a Richmond man was the sixth and final defendant to be sentenced for his role in a multi-state anabolic steroid conspiracy that operated across the country. According to court documents, Clyde Edward Peele, 46, is one of six members of a trafficking network, led by Michael...
Noviembre 02, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Septiembre 27, 2021
Newark, N.J. – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
Septiembre 27, 2021
Showing 1 - 10 of 18 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster